Socma Pushes for Greater U.S. Oversight of Overseas API Production

Socma has asked the U.S. FDA to beef up inspections of foreign facilities manufacturing active pharmaceutical ingredients (APIs). Socma and the Bulk Pharmaceuticals Task Force submitted comments on an FDA advisory panel’s recent report “FDA...

This information is only available to
Chemical Week 24/7 members and subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not a Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive        access of the last 2 years        of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers